Home R&D Page 6

R&D

NBTXR3 will be tested in combination with immune checkpoints inhibitors

A monoclonal antibody to treat atopic dermatitis

Four active substance together against HIV infection

Gene editing. The first recommendations on allowed use

Neurodegenerative diseases. The role of dopaminergic neurons

Good results for a phase I/II head and neck cancer trial

Results of the antibiotic cadazolid

Chinese cell therapy effective in small multiple myeloma trial

New vaccine to protect adolescent and adult from Men B

Exceptional curcumstances approval for dinutuximab beta in neuroblastoma

1...567...16Page 6 of 16
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151